MODEL-IN (222008)

  https://cordis.europa.eu/project/id/222008

  FP7 (2007-2013)

  Genomic determinants of inflammation: from physical measurements to system perturbation and mathematical modeling

  Multidisciplinary fundamental genomics and molecular biology approaches to study basic biological processes relevant to health and diseases (HEALTH-2007-2.1.2-5)

  genetics  ·  autoimmune diseases  ·  oncology  ·  mathematical model

  2008-12-01 Start Date (YY-MM-DD)

  2012-05-31 End Date (YY-MM-DD)

  € 3,962,778 Total Cost


  Description

Inflammation is a complex biochemical and cellular response essential for the viability of higher organisms because of its requirement in anti-microbial defence and protection from the consequences of tissue injury. However, uncontrolled or sustained inflammation leads to several diseases with a huge social impact, ranging from autoimmune diseases to septic shock and cancer. While the requirement for specific transcription factors (TF) in inflammatory gene transcription is known, quantitative models describing how their interactions with genomic sequences leads to normal or pathological outcomes are not available. Unravelling how genomic organization underlies the orchestrated expression of inflammatory genes is crucial to understand how to pharmacologically tune pathological inflammatory responses. Now is the right moment to tackle this question as for the first time we have genomic technologies and computational abilities to generate the necessary quantitative data and to build computational models describing spatiotemporal coordination of transcription of hundreds of inflammatory genes by multiple TFs. To implement this objective, we have assembled a consortium of top-level scientists in the European Research Area who reached documented excellence in complementary aspects of transcriptional control, namely quantitative measurement of TF-DNA interactions, in vitro and in vivo analysis of chromatin organization, manipulation of genomic sequences by homologous recombination, computational and systems biology applied to transcriptional circuits. The network provides the critical mass required to generate ample quantitative and complementary datasets describing the minimal transcriptional regulatory blocks relevant for inflammation, thus enabling the integration of their coordinated activities via systems approaches. Each research group complements the other participants and the whole projects, and as such this proposal can not be carried out on any individual level.


  Complicit Organisations

2 Israeli organisations participate in MODEL-IN.

Country Organisation (ID) VAT Number Role Activity Type Total Cost EC Contribution Net EC Contribution
Italy ISTITUTO EUROPEO DI ONCOLOGIA SRL (999969703) IT08691440153 participant PRC € 0 € 242,400 € 0
United Kingdom IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (999993468) GB649926678 participant HES € 0 € 331,011 € 0
United Kingdom OXFORD NANOPORE TECHNOLOGIES LTD (999703923) GB874642494 participant PRC € 0 € 90,000 € 0
Israel WEIZMANN INSTITUTE OF SCIENCE (999979306) IL520016858 participant HES € 0 € 166,380 € 0
France ECOLE NORMALE SUPERIEURE DE LYON (999868338) nan participant HES € 0 € 316,800 € 0
Germany UNIVERSITAT ZU KOLN (999852915) DE123486767 participant HES € 0 € 349,200 € 0
France UNIVERSITE JOSEPH FOURIER GRENOBLE 1 (999907429) FR07193818382 participant HES € 0 € 208,800 € 0
Israel THE HEBREW UNIVERSITY OF JERUSALEM (999975038) IL500701610 participant HES € 0 € 193,500 € 0
United Kingdom IC CONSULTANTS LTD (998830826) nan participant PRC € 0 € 261,536 € 0
United Kingdom THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (999984350) GB125506730 coordinator HES € 0 € 485,877 € 0
Italy UNIVERSITA VITA-SALUTE SAN RAFFAELE (999854467) IT13420850151 participant HES € 0 € 280,800 € 0